Immunohistochemical and Biochemical Measurement of Estrogen and Progesterone Receptors in Primary Breast Cancer Correlation of Histopathology and Prognostic Factors

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Annals of Surgery

• Publication date

  1993-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00000658-199307000-00004PMID 8328824PMCID PMC1242895
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic value of estrogen and progesterone receptors in primary breast cancer

  2005cited by this paper
• Long term analysis of factors influencing the outcome in carcinoma of the breast smaller than one centimeter.

  1992cited by this paper
• Immunocytochemical determination of estrogen receptor, progesterone receptor, and 1,25-dihydroxyvitamin D3 receptor in breast cancer and relationship to prognosis.

  1991cited by this paper
• Nuclear pleomorphism, a strong prognostic factor in axillary node-negative small invasive breast cancer

  1991cited by this paper
• Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer.

  1990cited by this paper
• Histologic grading and subfactor analysis as prognostic parameters in patients with breast cancer.

  1990cited by this paper
• Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival

  1990cited by this paper
• Nuclear polymorphism — a prognostic parameter to evaluate local recurrence of female breast cancer

  1990cited by this paper
• Prognostic value of histologic grade nuclear components of Scarff‐Bloom‐Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas

  1989cited by this paper
• Histopathologic characterization of human breast cancer in correlation with estrogen receptor status. A comparison of immunocytochemical and biochemical analysis

  1988cited by this paper
• Immunocytochemical localization of estrogen receptor in human breast tissue.

  1988cited by this paper
• Immunocytochemical detection of progesterone receptor in breast cancer with monoclonal antibody. Relation to biochemical assay, disease‐free survival, and clinical endocrine response

  1988cited by this paper
• Estrogen receptor protein of breast cancer in patients with positive nodes. High recurrence rates in the postmenopausal estrogen receptor-negative group.

  1987cited by this paper
• Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.

  1987cited by this paper
• [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue].

  1987cited by this paper
• Histologic malignancy grading of invasive ductal breast carcinoma. A regression analysis of prognostic factors in low‐risk carcinomas from a multicenter trial

  1987cited by this paper
• Estrogen and progesterone receptors in human breast cancer. Correlation with histologic subtype and degree of differentiation

  1986cited by this paper
• A multifactorial analysis of steroid hormone receptors in stages I and II breast cancer.

  1985cited by this paper
• Estrogen receptor protein of breast cancer as a predictor of recurrence

  1985cited by this paper
• Immunocytochemical study of mammalian progesterone receptor using monoclonal antibodies.

  1985cited by this paper
• Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.

  1984cited by this paper
• Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breast

  1982cited by this paper
• Oestrogen receptors in human breast cancer

  1982cited by this paper
• Estrogen and progesterone receptors in breast carcinoma: Correlations with epidemiology and pathology

  1981cited by this paper
• Estrogen receptor: A prognostic factor in breast cancer

  1981cited by this paper
• Oestrogen receptor values and histological grade in human breast cancer

  1981cited by this paper
• Steroid receptors in early breast cancer: value in prognosis.

  1981cited by this paper
• Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer

  1980cited by this paper
• The value of estrogen and progesterone receptors in the treatment of breast cancer

  1980cited by this paper
• The histopathological evaluation of human breast cancers in correlation with estrogen receptor values

  1980cited by this paper
• Monoclonal antibodies to estrophilin: probes for the study of estrogen receptors.

  1980cited by this paper
• Correlation of estrogen receptor levels with histology and cytomorphology in human mammary cancer.

  1979cited by this paper
• Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.

  1977cited by this paper
• Pathological review of breast lesions analyzed for estrogen receptor protein.

  1975cited by this paper
• Histological Grading and Prognosis in Breast Cancer

  1957cited by this paper

• Integrating multimodal cancer data using deep latent variable path modelling

  2025cites this paper
• Immunohistochemistry Screening of Different Tyrosine Kinase Receptors in Canine Solid Tumors—Part I: Proposal of a Receptor Panel to Predict Therapies

  2024cites this paper
• Cell State Transitions and Phenotypic Heterogeneity in Luminal Breast Cancer Implicating MicroRNAs as Potential Regulators

  2023cites this paper
• Prognostic significance of TM4SF1 and DDR1 expression in epithelial ovarian cancer

  2023cites this paper
• No Association between ABCB1 G2677T/A or C3435T Polymorphisms and Survival of Breast Cancer Patients—A 10-Year Follow-Up Study in the Polish Population

  2022cites this paper
• Nuclear receptors in oral cancer-emerging players in tumorigenesis.

  2022cites this paper
• Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects

  2022cites this paper
• Molecular Classification of Breast Carcinoma Based on the Prognostic Marker: A Clinico-pathological Correlation

  2022cites this paper
• Tubular Carcinoma of the Breast: A Clinicopathological Analysis of Two Cases

  2022cites this paper
• A Study of Hormone Receptor Status in Breast Carcinoma and Their Histopathological Correlation

  2021cites this paper
• Comparison of breast cancer surrogate subtyping using a closed-system RT-qPCR breast cancer assay and immunohistochemistry on 100 core needle biopsies with matching surgical specimens

  2021cites this paper
• An overview of breast cancer: Classification and related signaling pathways

  2021cites this paper
• Prognostic Signi cance of TM4SF1 and DDR1 Expression in Ovarian Cancer

  2021cites this paper
• Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis

  2021cites this paper
• Indoleamine 2,3-Dioxygenase-1 Expression in Adrenocortical Carcinoma.

  2020cites this paper
• Intrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1

  2020cites this paper
• Hormonal Receptors, Human Epidermal Growth Factor Receptor-2 and Triple Negative Immunohistochemical Typing in Women with Breast Cancer in Kampala, Uganda

  2020cites this paper
• Inhibition of Microbial Beta-Glucuronidase Does Not Prevent Breast Carcinogenesis in the Polyoma Middle T Mouse

  2019cites this paper
• Expression of programmed death ligand 1 and 2 in adrenocortical cancer tissues: An exploratory study

  2019cites this paper
• Incidence of triple negative breast cancer at Rajendra Institute of Medical Sciences, Ranchi

  2019cites this paper
• The ESR 1 and GPX 1 gene expression level in human malignant and nonmalignant breast tissues

  2018cites this paper
• Macrodissection prior to Closed System RT-qPCR is not necessary for Estrogen Receptor and HER2 Concordance with IHC/FISH in Breast Cancer

  2018cites this paper
• Enhancement of the bioavailability of a novel anticancer compound (acetyltanshinone IIA) by encapsulation within mPEG-PLGA nanoparticles: a study of formulation optimization, toxicity, and pharmacokinetics

  2017cites this paper
• Characterization of hormonal receptors and human epidermal growth factor receptor-2 in tissues of women with breast cancer at Muhimbili National Hospital, Dar es salaam, Tanzania

  2017cites this paper
• Computational Investigation of Homologous Recombination DNA Repair Deficiency in Sporadic Breast Cancer

  2017cites this paper
• Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer.

  2017cites this paper
• Detection and evaluation of estrogen DNA‐adducts and their carcinogenic effects in cultured human cells using biotinylated estradiol

  2017cites this paper
• Dual functional small molecule fluorescent probes for image-guided estrogen receptor-specific targeting coupled potent antiproliferative potency for breast cancer therapy.

  2017cites this paper
• Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate.

  2016cites this paper
• Hormonal Receptor, Human Epidermal Growth Factor and Its Association with Breast Cancer Tumor Characteristics in Albania.

  2016cites this paper
• Deciphering the divergent roles of progestogens in breast cancer

  2016cites this paper
• p53 as a prognostic marker in carcinoma breast in correlation with conventional estrogen and progesterone hormone receptors

  2016cites this paper
• Less Common Triple Negative Breast Cancers

  2016cites this paper
• The Comparison of Stereological Calculations of Tumour Volume with Prognostic Parameters in Breast Cancer

  2016cites this paper
• Post-Mastectomy Radiation Therapy for Invasive Lobular Carcinoma: A Comparative Utilization and Outcomes Study.

  2016influential citation
• The influence of steroid receptor status on the cardiotoxicity risk in HER2-positive breast cancer patients receiving trastuzumab

  2015cites this paper
• Invasive Lobular Carcinoma: MRI Features and Clinicohistological Characteristics According to the ER, PR, and HER2 Statuses

  2015cites this paper
• Running Title: Mouse models of metastatic breast cancer

  2015cites this paper
• Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer

  2015cites this paper
• Comparative analysis of imaging and pathology features of mucinous carcinoma of the breast.

  2015cites this paper
• Tumor-Associated Carbonic Anhydrases IX and XII

  2015cites this paper
• CORRELATION BETWEEN HORMONES RECEPTOR (ER&PR) ANDTUMOR GRADE AMONG SUDANESE FEMALE BREAST CANCER PATIENTS

  2015influential citation
• A novel anti-cancer agent, acetyltanshinone IIA, inhibits oestrogen receptor positive breast cancer cell growth by down-regulating the oestrogen receptor.

  2014cites this paper
• Immunohistochemistry subtypes (ER/PR/HER) of breast cancer: where do we stand in the West of Saudi Arabia?

  2014cites this paper
• Trends in the distribution of breast cancer over time in the southeast of Scotland and review of the literature

  2014cites this paper
• THE IMPORTANCE OF PROGNOSTIC FACTORS (ER, PR, P53) IN BREAST CANCER AND THEIR RELATIONSHIP WITH STAGE OF DISEASE

  2014cites this paper
• Estrogen Receptors in Immunohistochemically Stained Slides: Comparing Subjective and Computerized Evaluation Methods

  2014cites this paper
• A study to determine the incidence of estrogen receptor (ER) and progesterone receptor (PR) expression in different histological grades of breast cancer

  2014cites this paper
• Chirurgische Klinik und Hochschulambulanz I Allgemein-, Viszeral- und Gef äß chirurgie der Medizinischen Fakult ä t Charit é - Universit ä tsmedizin Berlin

  2014cites this paper
• Role of the WNT-regulated transcription cofactor LBH in normal and neoplastic mammary stem cell control

  2013cites this paper
• COREGULATORS AND THEIR ROLE IN SELECTIVE ESTROGEN RECEPTOR MODULATOR ACTION

  2013cites this paper
• Characterization of estrogen‐receptor‐targeted contrast agents in solution, breast cancer cells, and tumors in vivo

  2013cites this paper
• Special Types of Breast Carcinoma

  2012cites this paper
• Application of Chromosome Conformation Capture (3C) to the Study of Human Genetic Disease

  2012cites this paper
• Correlations of Hormone Receptors (ER and PR), Her2/neu and p53 Expression in Breast Ductal Carcinoma Among Yemeni Women

  2011cites this paper
• Protein Microarray-based Comparison of HER2, Estrogen Receptor, and Progesterone Receptor Status in Core Biopsies and Surgical Specimens From FFPE Breast Cancer Tissues

  2011cites this paper
• Breast Cancer: PTEN Expression in Palestinian Women Triple Negative Subtype

  2011cites this paper
• Triple‐negative breast cancer in Hispanic patients

  2011cites this paper
• Late age at first full term birth is strongly associated with lobular breast cancer

  2011cites this paper
• Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy

  2010cites this paper
• Hormone receptors and other prognostic factors in breast cancer in Cuba.

  2010cites this paper
• Hormone receptors and other prognostic factors in breast cancer in Cuba.

  2010cites this paper
• Favorable Histologic Type Breast Cancer in Lampang Hospital; Clinical Presentation and Outcome

  2010cites this paper
• Detection of HER2 amplification using the SISH technique in breast, colon, prostate, lung and ovarian carcinoma.

  2010cites this paper
• The contribution of postmenopausal hormone use cessation to the declining incidence of breast cancer

  2010cites this paper
• Postmenopausal Hormone Replacement Therapy and Breast Cancer – Clinicopathologic Associations and Molecular Mechanisms

  2010cites this paper
• The role of genetics in breast and reproductive cancers

  2010cites this paper
• Inmunohistochemical Evaluation of Estrogen Receptors Alpha and Beta in Normal Inferior Turbinate Mucosa

  2010cites this paper
• Transcription Cofactor LBH is a Direct Target of the Oncogenic WNT Pathway with an Important Role in Breast Cancer

  2010cites this paper
• Identification and characterization of estrogen receptor-regulated gene expression programs

  2010cites this paper
• Evaluación Inmunohistoquímica de los Receptores de Estrógenos Alfa y Beta en la Mucosa Normal de Concha Nasal Inferior

  2010cites this paper
• Integrated analysis of breast cancer cell lines reveals unique signaling pathways

  2009cites this paper
• Imaging , Diagnosis , Prognosis Microarray-Based Determination of Estrogen Receptor , Progesterone Receptor , and HER 2 Receptor Status in Breast Cancer

  2009cites this paper
• Microarray-Based Determination of Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Status in Breast Cancer

  2009cites this paper
• Somatic Alterations and Implications in Breast Cancer

  2009cites this paper
• Prävalenz und klinische Relevanz der Östrogen Rezeptor Amplifikation beim Mammakarzinom

  2009cites this paper
• Differentiated expression of estrogen receptors (ER) and progesterone receptors (PgR) in ductal breast cancers.

  2009cites this paper
• Bedeutung der Steroidrezeptoren beim primären Mammakarzinom

  2009cites this paper
• Menopausal Hormone Therapy and Risk of Clinical Breast Cancer Subtypes

  2009cites this paper
• Progestagens Use Before Menopause and Breast Cancer Risk According to Histology and Hormone Receptors

  2008cites this paper
• Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry.

  2008cites this paper
• Receptores Hormonales y otros Factores Pronósticos en Cáncer de Mama en Cuba

  2008cites this paper
• Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer.

  2008cites this paper
• Reproductive Factors, Age at Maximum Height, and Risk of Three Histologic Types of Breast Cancer

  2008cites this paper
• Epidemiology, screening and diagnosis of breast cancer in the Asia–Pacific region: Current perspectives and important considerations

  2008cites this paper
• Prevalence of hormone receptors and HER2/neu in breast cancer cases in Jordan

  2008cites this paper
• Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells

  2008cites this paper
• The role of progesterone receptors in breast and endometrial cancer

  2008cites this paper
• Nuclear receptors and coregulators in inflammation and cancer.

  2008cites this paper
• Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state

  2007cites this paper
• Tumor Size and Pathologic Characteristics of Breast Cancer Analysis of 639 Early Breast Cancers

  2007cites this paper
• Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study.

  2007cites this paper
• A comparison between the novel rabbit monoclonal antibodies (SP1 and B644) and mouse antibodies for evaluating estrogen receptor in breast tumors

  2007cites this paper
• Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer

  2007cites this paper
• Interactions between Body Mass Index and Hormone Therapy and Postmenopausal Breast Cancer Risk (United States)

  2006cites this paper
• The impact of socio-economic factors on outcome from breast cancer

  2006cites this paper
• Relationship between Established Breast Cancer Risk Factors and Risk of Seven Different Histologic Types of Invasive Breast Cancer

  2006cites this paper
• High Progesterone Receptor Expression Correlates to the Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer Patients

  2006cites this paper
• Evaluation of the relationship between human epidermal growth factor receptor-2/neu (c-erbB-2) amplification and pathologic grading in patients with breast cancer.

  2006cites this paper
• Association of the Progesterone Receptor Gene with Breast Cancer Risk: A Single-Nucleotide Polymorphism Tagging Approach

  2006cites this paper